Immatics (IMTX) Change in Accured Expenses (2019 - 2024)

Immatics (IMTX) reported Change in Accured Expenses of -$34.4 million for Q1 2024, down 311.37% on a YoY basis from $16.3 million in Q2 2023, and down 303.35% sequentially from $16.9 million in Q4 2023.

Immatics (IMTX) Change in Accured Expenses (2019 - 2024) Analysis & Trends

Immatics (IMTX) has 6 years of Change in Accured Expenses data on file, last reported at -$34.4 million in Q1 2024.

  • For the quarter ending Q1 2024, Change in Accured Expenses fell 311.37% year-over-year to -$34.4 million; the trailing twelve-month figure through Mar 2024 stood at -$26.0 million (down 433.43% YoY), and the FY2025 full-year result was -$42.5 million, up 73.78% from the prior year.
  • Change in Accured Expenses fell to -$34.4 million in Q1 2024, from $16.9 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $68.4 million in Q2 2022 to a low of -$39.4 million in Q4 2022.
  • A 5-year average of -$2.7 million and a median of -$6.3 million in 2023 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses surged 1304.44% in 2022 and plunged 311.37% in 2024, its largest moves.
  • Tracing IMTX's Change in Accured Expenses over 5 years: stood at -$11.0 million in 2020, then tumbled by 82.9% to -$20.1 million in 2021, then sank by 96.28% to -$39.4 million in 2022, then surged by 142.94% to $16.9 million in 2023, then tumbled by 303.35% to -$34.4 million in 2024.
  • Business Quant data shows IMTX's Change in Accured Expenses at -$34.4 million in Q1 2024, $16.9 million in Q4 2023, and -$6.3 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.13 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 931,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -16.74 Mn
10 Immatics 1.06 Bn 515.66 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 -34.41 Mn
Mar 31, 2024 -34.41 Mn
Dec 31, 2023 16.92 Mn
Dec 31, 2023 16.92 Mn
Sep 30, 2023 -6.26 Mn
Sep 30, 2023 -6.26 Mn
Jun 30, 2023 -2.28 Mn
Jun 30, 2023 -2.28 Mn
Mar 31, 2023 -8.36 Mn
Mar 31, 2023 -8.36 Mn
Dec 31, 2022 -39.41 Mn
Dec 31, 2022 -39.41 Mn
Sep 30, 2022 -12.85 Mn
Sep 30, 2022 -12.85 Mn
Jun 30, 2022 68.43 Mn
Jun 30, 2022 68.43 Mn
Mar 31, 2022 36.81 Mn
Mar 31, 2022 36.81 Mn
Dec 31, 2021 -20.08 Mn
Dec 31, 2021 -20.08 Mn